BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11688338)

  • 1. Increasing incidence of end-stage renal disease in Wisconsin: an unintended consequence of increased survival?
    Russell A; Remington P; D'Alessio D; Brazy P
    WMJ; 2001; 100(6):35-8. PubMed ID: 11688338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States.
    Fatica RA; Port FK; Young EW
    Am J Kidney Dis; 2001 Jun; 37(6):1184-90. PubMed ID: 11382687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
    Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends of incident dialysis patients in Tunisia between 1992 and 2001.
    Counil E; Cherni N; Kharrat M; Achour A; Trimech H
    Am J Kidney Dis; 2008 Mar; 51(3):463-70. PubMed ID: 18295062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
    Stewart JH; McCredie MR; Williams SM; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of end stage renal disease in Wisconsin: 1982-1990.
    Sleath B; Remington P
    Wis Med J; 1992 Jun; 91(6):303-5. PubMed ID: 1471372
    [No Abstract]   [Full Text] [Related]  

  • 14. An improved understanding of the causes of end-stage renal disease.
    Young EW
    Semin Nephrol; 1997 May; 17(3):170-5. PubMed ID: 9165646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history of end-stage renal disease among hemodialyzed patients in Poland.
    Gumprecht J; Zychma MJ; Moczulski DK; Gosek K; Grzeszczak W
    J Nephrol; 2003; 16(4):511-5. PubMed ID: 14696752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End stage kidney disease: increasing incidence in Virginia.
    Moore MA
    Va Med Q; 1993; 120(2):99-103. PubMed ID: 8481420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.
    Kitiyakara C; Eggers P; Kopp JB
    Am J Kidney Dis; 2004 Nov; 44(5):815-25. PubMed ID: 15492947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1097-100. PubMed ID: 16267496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.